Low-dose Theophylline as Anti-inflammatory Enhancer in Severe Chronic Obstructive Pulmonary Disease (ASSET)
This study is currently recruiting participants.
Verified May 2012 by Hospital Son Espases
Sponsor:
Hospital Son Espases
Collaborators:
Spanish Research Center for Respiratory Diseases
Fundación Mutua Madrileña
Information provided by (Responsible Party):
Borja Cosio, Hospital Son Espases
ClinicalTrials.gov Identifier:
NCT01599871
First received: May 14, 2012
Last updated: May 15, 2012
Last verified: May 2012
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study is currently recruiting participants. |
|---|---|
| Estimated Study Completion Date: | March 2014 |
| Estimated Primary Completion Date: | December 2013 (Final data collection date for primary outcome measure) |